Xolair 300 MG/2 ML autoinject 2ML
Ended Awarded
- Contract number
- SPE2DB25FX2ER
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $34,245
Award facts
- Contract value 100% obligated
- $34,244.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
On September 17, 2025, the Defense Logistics Agency (DLA) awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 300 mg/2 mL auto-injector units. The contract, valued at $34,244.60 on a firm fixed-price basis, represents a delivery order issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which carries a total ceiling value of $499,999,999 and extends through November 2026. The delivery order carries an ultimate completion date of October 8, 2025, and no set-aside designation was utilized in this award.
This delivery order exemplifies the DLA's strategic reliance on DMS Pharmaceutical Group for pharmaceutical supply chain support to Department of Defense healthcare facilities. As a specialized pharmaceutical wholesaler with an established track record of federal contracting since 2001, DMS Pharmaceutical Group provides branded and generic prescription drugs, biologics, and medical consumables to military health facilities nationwide. The Xolair product being delivered under this order serves the respiratory and allergic disease treatment needs of military personnel and their families through the Defense health system.
Quick answers
Who was awarded contract SPE2DB25FX2ER?
SPE2DB25FX2ER was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 17, 2025.
How much is contract SPE2DB25FX2ER worth?
The government has obligated $34,245 on SPE2DB25FX2ER.
Is contract SPE2DB25FX2ER an order under another contract?
Yes. SPE2DB25FX2ER is a delivery order under SPE2DB22D9353, an indefinite delivery contract.
Was contract SPE2DB25FX2ER competed?
The extent of competition for SPE2DB25FX2ER was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award